Fig. 1 | Nature Communications

Fig. 1

From: Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes

Fig. 1

Enrollment of patients for poly-ligand profiling. The flow chart illustrates the rationale and the numbers of patients for inclusion in the test set and those used for the ssDNA library enrichment. A comparative analysis of the demographic and clinical details for the excluded 78 patients and the enrolled 67 patients (Supplementary Data 2) shows no bias among tested clinical and demographic factors, thus the 67 enrolled cases are representative

Back to article page